» Articles » PMID: 18304460

Expression of Nucleostemin in Prostate Cancer and Its Effect on the Proliferation of PC-3 Cells

Overview
Specialty General Medicine
Date 2008 Feb 29
PMID 18304460
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nucleostemin is essential for the proliferation and survival of stem and cancer cells, but it is unknown whether this newly identified molecule is involved in prostate cancer pathogenesis.

Methods: Total RNA and protein were extracted from prostate cancer tissues and PC-3, LNCap and DU145 cell lines. The nucleostemin mRNA and protein expression were measured by RT-PCR and Western blot. Immunohistochemistry was also used to detect the nucleostemin protein expression in prostate cancer tissues and PC-3 cells. A nucleostemin specific, short hairpin RNA, expression plasmid was used to transfect PC-3 cells. The changes of nucleostemin gene were detected and the proliferative capacity of the cells was determined.

Results: Nucleostemin was highly expressed in prostate cancer tissues and cell lines. Nucleostemin expression level in the silencer group PC-3 cells remarkably reduced. The proliferation rate of silencer group PC-3 cells decreased and the percentage of G1 stage cells increased. The neoplasm forming capacity in nude mice of the silencer group PC-3 cells decreased significantly.

Conclusions: Nucleostemin is highly expressed in prostate cancer tissues and cell lines. The proliferative capacity of PC-3 cells is remarkably reduced after silencing nucleostemin gene expression.

Citing Articles

GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer.

Kumar S, Shuaib M, Alasmari A, Alqahtani F, Gupta S Cancers (Basel). 2023; 15(10).

PMID: 37345060 PMC: 10216705. DOI: 10.3390/cancers15102723.


Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer.

Zhang Y, Wang Y, Meng L, Huang Q, Zhu Y, Cui W J Nanobiotechnology. 2021; 19(1):17.

PMID: 33422073 PMC: 7796562. DOI: 10.1186/s12951-020-00756-6.


Differential expression of nucleostemin in the cytoplasm and nuclei of normal and cancerous cell lines.

Kavyasudha C, Joel J, Devi A Turk J Biol. 2019; 42(3):250-258.

PMID: 30814887 PMC: 6353292. DOI: 10.3906/biy-1712-10.


Gene expression profiling of NB4 cells following knockdown of nucleostemin using DNA microarrays.

Sun X, Jia Y, Wei Y, Liu S, Yue B Mol Med Rep. 2016; 14(1):175-83.

PMID: 27374947 PMC: 4918620. DOI: 10.3892/mmr.2016.5213.


Comparison of gene expression of SOX2 and OCT4 in normal tissue, polyps, and colon adenocarcinoma using immunohistochemical staining.

Talebi A, Kianersi K, Beiraghdar M Adv Biomed Res. 2015; 4:234.

PMID: 26645019 PMC: 4647122. DOI: 10.4103/2277-9175.167958.